Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Showing 10 out of 107 products:
ICAD (zeige DFFA Antikörper) cDNA was 844-bp in length, containing a 522-bp open reading frame which encoded a protein of 174 amino acids.
High Cideb expression is associated with Ulcerative Colitis.
CIDEB interacts with the HCV NS5A protein, and the N terminus of CIDEB and the domain I of NS5A are involved in this interaction.
these data revealed that Cideb plays an important role in controlling intestinal chylomicron lipidation.
this study shows that C5a signaling induces apoptosis in brain vascular endothelial cells in experimental lupus through activation of CIDEB
CIDEB downregulation may contribute to HCV-induced hepatic steatosis
CIDEB can act as an anti-HCV host factor and contribute to altered triglyceride homeostasis.
Authors found CIDEB to be an essential cofactor for hepatitis C virus entry into hepatocytes.
this work highlights CIDEB's role in lipid droplet (LD) fusion, and presents a new model system to study the PGC-1alpha/CIDEB pathway's role in LD dynamics and the VLDL pathway.
CIDE proteins expression correlate with tumor and survival characteristics in patients with renal cell carcinoma (zeige MOK Antikörper).
PGC-1alpha plays an important role in partitioning cytoplasmic TG toward the VLDL secretory compartments and promoting VLDL secretion via transcriptional induction of CideB.
Data (including data from studies in knockout mice) suggest Cideb promotes lipid storage as droplets in hepatocytes under normal diet conditions; Cidea (zeige CIDEA Antikörper)/Cidec (zeige CIDEC Antikörper) promote fusion of lipid droplets leading to liver steatosis in fasting (16h) and obese mice.
Cideb and perilipin 2 (zeige PLIN2 Antikörper) play opposing roles in controlling VLDL lipidation and hepatic lipid homeostasis
SREBP-1c (zeige SREBF1 Antikörper) mediates the effect of insulin (zeige INS Antikörper) on the expression of Cidea (zeige CIDEA Antikörper) in mouse hepatocytes.
Data suggest that Cideb is a novel regulator in controlling cholesterol homeostasis in the liver.
Cideb is a novel important regulator in lipid metabolism in the liver and may thus represent a new therapeutic target for the treatment of obesity, diabetes, and liver steatosis
Cideb protein promotes the formation of triacylglycerol-enriched VLDL particles and provides a molecular insight into VLDL lipidation and maturation in hepatocytes.
We therefore speculate that CIDEb may play a contrary role to the other CIDEs. The basic molecular information we provide here will be useful for further investigations of the physiological function of the gene, which will be helpful in better understanding the role of the CIDE family in lipid metabolism in pig models.
cell death-inducing DFFA-like effector b
, cell death-inducing DNA fragmentation factor, alpha subunit-like effector B
, cell death activator CIDE-B
, cell death activator cide-b
, Cell death activator CIDE-B (Cell death-inducing DFFA-like effector B)
, DFFA-like B
, cell death-inducing DFFA-like effector B